Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
Full-Text Search:
Chinese Journal of New Drugs
FQ: 半月
AD of Publication: 北京市
Lanuage: 中文;
ISSN: 1003-3734
CN: 11-2850/R
YP: 1992
Url: 中国医药科技出版社;中国医药集团总公司;中国药学会
Recommended Journals
Chinese Journal of New Drugs
2007 -01
Catalog
Roles of P53 and its signaling pathway in tumor resistance YANG A-jing1,WANG Xue-mei2,LI Dian-dong1,WANG Zhen1(1 Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100050,China;2 The People's Hospital of Liaocheng City,Liaocheng 252000,China)
Development progresses of heparan sulfate polysaccharide analogs with anti-breast cancer activity XIE Shao-fan1,2,LIU Xin2,JIANG Ming2,LIU Chang-lin1,LIU Jian-feng2(1 Deparment of Chemistry,2 School of Life Science and Technology,HuazhongUniversity of Science and Technology,Wuhan 430074,China)
Antitumor agents: multidrug resistance and enhanced permeability and retention SUN Xiao-fei,XU Qiong-ming,AO Gui-zhen,ZHANG Jian(Suzhou University,Suzhou 215123,China)
Anticancer mechanisms and clinical effects of FK228 LI Lei,WANG Pu(School of Pharmaceutical Science,Shandong University,Jinan 250012,China)
Research advance of ursolic acid MENG Yan-qiu,CHEN Yu,WANG Zan,LIU Dan(Pharmaceutical Engineering Department,Shenyang Institute of Chemical Technology,Shenyang 110142,China)
Advances on the research of doxorubicin loaded polymeric micelles XU Xiang-yang1,2,LI Ling2,ZHOU Jian-ping2(1 Jiangsu Simcere Pharmaceutical R&D Co.,LTD,Nanjing 210042,China;2 Department of Pharmacy,China Pharmaceutical University,Nanjing 210009,China)
Expression of CD_(44)V6 and CD_(49) in Lewis mice lung carcinoma cells by Feiliuping Ⅱ FENG Li1,HUA Bao-jin2,PIAO Bing-kui2,WANG Fang1(1 Department of Oncology,Wangjing Hospital Affiliated to China Science Academyof Traditional Chinese Medicine,Beijing 100102,China;2 Department of Oncology,GuanganmenHospital Affiliated to China Science Academy of Traditional Chinese Medicine,Beijing 100053,China)
Effects of curcumin on abnormal cell cycle and apoptosis of serum-deprived PC12 cells induced by β-amyloid peptide(25-35) XIE Zhao-yang1,2,ZHU Qi-feng1,WU Bin-hua2(1 Institute of Biochemistry and Molecular Biology,2 Institute of Medical Laboratory,Guangdong Medical College,Zhanjiang 524023,China)
Expression of mitochondrial prohibitin in paclitaxol-resistant CCRF-CEM cells ZHU Jin-wu1,QIAN Zhi-yu1,GUAN Yong-biao2(1 Department of Pharmacology,China Pharmaceutical University,Nanjing 210009,China;2 Department of Drug Safety Evaluation and Research,Beijing Institute ofPharmacology and Toxixology,Beijing 100850,China)
Improvement of mice immune function with compounds of powdered Maca(Lepidium meyenii) and ginsenosides JIN Wen-wen,ZHANG Yong-zhong,AO Ming-zhang,XIONG Yue,YU Long-jiang(School of Life Science and Technology,Huazhong University of Scienceand Technology,Wuhan 430074,China)
Uptake determination of sophocarpine in Caco-2 cells by LC-MS WANG Su-jun1,2,LI Xiao-tian2,3,WANG Guang-ji2,RUAN Jin-xiu1,ZHANG Zhen-qing1(1 Institute of Pharmacology and Toxicology,Academy of Military Medical Sciences,Beijing 100850,China;2 Key Lab of Drug Metabolism and Pharmacokinetics,China Pharmaceutical University,Nanjing 210038,China;3 School of Pharmacy,Zhengzhou University,Zhengzhou 450052,China)
Metabolites of endophyte HCCB00189 RUAN Li-jun1,SHANG Xin-yan2,GE Mei1,3,CHEN Dai-jie1,3,ZHU Bao-quan1(1 Shanghai Institute of Pharmaceutical Industry,Shanghai 200040,China;2 College of Life Science and Technology,China Pharmaceutical University,Nanjing 210009,China;3 Shanghai Health Creation Center for Biopharmaceuticals R&D,Shanghai 201203,China)
Stability determination of fluorouracil in implants under the high-temperature fusion by infrared spectroscopy XU Yuan-yuan1,WANG Wei-wei1,WANG Shi-liang2,MA Xiao-qin2, HU Ke-ling3,CHU Cheng-ding1,2,YAO Yu-you1(1 Anhui Medical University,Hefei 230032,China;2 Hefei University of Technology,Hefei 230009,China;3 University of Science and Technology of China,Hefei 230026,China)
Determination of entrapment efficiency of topotecan liposomes by ultrafiltration-HPLC LI Bao-qi,DENG Ying-jie,YANG Jing-wen(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
Preparation of ovalbumin nanoparticles with trimethyl chitosan chloride CAO Cui-zhen,ZONG li,CHEN li,ZHANG Yu-yun(Pharmaceutical Research Institute,China Pharmaceutical University,Nanjing 210009,China)
Assay of HZ08 and its related substances test by RP-HPLC WENG Jing-yan1,HANG Tai-jun1,ZHANG Hui-bin2,HUANG Wen-long2(1 Department of Pharmaceutical Analysis,2 Center of Drug Discovery,ChinaPharmaceutical University,Nanjing 210009,China)
RP-HPLC determination of raw sophoridine and sophoridine for injections ZHANG Ai-hua1,ZHANG Yue-han1,CHEN Xi-ju1,WU Lian-kui1,LI Xue-mei2(1 Jiangxi Institute of Materia Medica,Nanchang 330029,China;2 Jiangxi College of Chinese Traditional Medicine,Nanchang 330006,China)
Phase Ⅰ clinical tolerance trial of recombinant human Apo-2 ligand in patients with advanced cancer ZHOU Sheng-yu,CHEN Shan-shan,LIU Peng,LUO Yang,XING Pu-yuan,HE Jing,SHI Yuan-kai,FENG Feng-yi(Department of Medical Oncology,Cancer Hospital,Chinese Academy ofMedical Sciences & Peking Union Medical College,Beijing 100021,China)
Phase I clinical trial of salvicine in patients with solid tumors LUO Zhi-guo1,2,ZHOU Sheng-yu1,ZHANG Pin1,WANG Xing-yuan1,HE Jing1,XING Pu-yuan1,LIU Peng1,FENG Feng-yi1(1 Department of Medical Oncology,Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China;2 Department of Medical Oncology,Cancer Hospital,Fudan University,Shanghai 200032,China)
PhaseⅠhuman tolerability trial of gambogic acid ZHOU Zheng-tao1,2,WANG Jin-wan1(1 Cancer Institute &Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;2 Department of Oncology,Yichang Central Hospital,Yichang 443000,China)
Efficacy of injections for expelling phlegm and heat in patients with postoperational complications of liver cancer WEI Min,XIAO Yi(The Fifth Hospital of Guangxi Medical University,Liuzhou 545001,China)
Sorafenib: pharmacology and clinical studies Lü Yun-feng1,FENG Yu-fei2,HU Xin2,BI Kai-shun1(1 Department of Pharmaceutical Analysis,College of Pharmaceutical Science,ShenyangPharmaceutical University,Shenyang 110016,China;2 Department of Pharmacy,Beijing Hospital,Ministry of Health,Beijing 100730,China)
Sunitinib: a novel multitargeted receptor tyrosine kinase inhibitor OU Yang1,FU De-xing2,GUO Xiu-li1(1 Department of New Drug Pharmacology,School of PharmaceuticalSciences,Shandong University,Jinan 250012,China;2 Department of Pharmacy,Beijing Hospital,Ministry of Health,Beijing 100730,China)
2007 Issues:  [01] [02] [03] [04] [05] [06] [07] [08] [09] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24]
More Issues:   [1992]   [1993]   [1994]   [1995]   [1996]   [1997]   [1998]   [1999]   [2000]   [2001]   [2002]   [2003]   [2004]   [2005]   [2006]   [2008]   [2009]   [2010]   [2011]   [2012]   [2013]   [2014]   [2015]   [2016]   [2017]   [2018]
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved